Erik Dubberke, MD
Washington University School of Medicine
4990 Children's Place
St. Louis,
MO
USA
63110
Papers:
2E-5
COST-EFFECTIVENESS OF BEZLOTOXUMAB+STANDARD OF CARE (SOC) VERSUS PLACEBO+SOC FOR THE PREVENTION OF RECURRENT CLOSTRIDIUM DIFFICILE INFECTION IN THE UNITED STATES